佰金生命科学(01466.HK)因可换股债券获兑换发行1.2亿股

Core Viewpoint - The company Baijin Life Sciences (01466.HK) has announced the issuance of 120 million shares following the conversion of convertible bonds worth HKD 31.5 million at a conversion price of HKD 0.2628 per share, impacting its existing share capital structure significantly [1] Group 1 - The company received a conversion notice from bondholders on September 29, 2025, regarding the exercise of conversion rights attached to the convertible bonds [1] - The newly issued shares represent approximately 15.52% of the company's existing issued share capital and about 13.43% of the expanded issued share capital post-conversion [1] - The shares were allotted and issued to the bondholders on October 8, 2025 [1]